Tumour-derived exosomes and their emerging roles in leukaemia (Review)

被引:2
|
作者
Chen, Lei [1 ]
Xie, Ting [2 ]
Wei, Bing [3 ]
Di, Da-Lin [3 ]
机构
[1] Weifang Med Univ, Affiliated Hosp, Dept Hematol, Weifang 261031, Shandong, Peoples R China
[2] Weifang Med Univ, Sch Clin Med, Weifang 261053, Shandong, Peoples R China
[3] Weifang Med Univ, Dept Immunol, 7166 Baotongxi St, Weifang 261053, Shandong, Peoples R China
关键词
exosomes; leukaemia; biomarkers; vaccine development; drug carriers; ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; BONE-MARROW MICROENVIRONMENT; MESENCHYMAL STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; STROMAL CELLS; DENDRITIC CELLS; IN-VITRO; T-CELL; INDUCE;
D O I
10.3892/etm.2023.11825
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Exosomes are small vesicles with a diameter of similar to 40-100 nm that are secreted by the majority of endogenous cells under normal and pathological conditions. They contain abundant proteins, lipids, microRNAs, and biomolecules such as signal transduction molecules, adhesion factors and cytoskeletal proteins, and play an important role in exchanging materials and transmitting information between cells. Recent studies have shown that exosomes are involved in the pathophysiology of leukaemia by affecting the bone marrow microenvironment, apoptosis, tumour angiogenesis, immune escape and chemotherapy resistance. Furthermore, exosomes are potential biomarkers and drug carriers for leukaemia, impacting the diagnosis and treatment of leukaemia. The present study describes the biogenesis and general characteristics of exosomes, and then highlight the emerging roles of exosomes in different types of leukaemia. Finally, the value of clinical application of exosomes as biomarkers and drug carriers is discussed with the aim to provide novel strategies for the treatment of leukaemia.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Role of tumour-derived exosomes in metastasis
    Bai, Suwen
    Wei, Yuan
    Liu, Rong
    Xu, Ruihuan
    Xiang, Li
    Du, Juan
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [2] Malignant effusions and immunogenic tumour-derived exosomes
    Andre, F
    Schartz, NEC
    Movassagh, M
    Flament, C
    Pautier, P
    Morice, P
    Pomel, C
    Lhomme, C
    Escudier, B
    Le Chevalier, T
    Tursz, T
    Amigorena, S
    Raposo, G
    Angevin, E
    Zitvogel, L
    [J]. LANCET, 2002, 360 (9329): : 295 - 305
  • [3] The contribution of tumour-derived exosomes to the hallmarks of cancer
    Meehan, Katie
    Vella, Laura J.
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2016, 53 (02) : 121 - 131
  • [4] Tumour-derived exosomes: Tinyenvelopesfor big stories
    Miller, Isabella V.
    Grunewald, Thomas G. P.
    [J]. BIOLOGY OF THE CELL, 2015, 107 (09) : 287 - 305
  • [5] Tumour-derived exosomes in liver metastasis: A Pandora's box
    Li, Sini
    Qu, Yan
    Liu, Lihui
    Wang, Chao
    Yuan, Li
    Bai, Hua
    Wang, Jie
    [J]. CELL PROLIFERATION, 2023, 56 (10)
  • [6] Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression
    Nuzhat, Zarin
    Kinhal, Vyjayanthi
    Sharma, Shayna
    Rice, Gregory E.
    Joshi, Virendra
    Salomon, Carlos
    [J]. ONCOTARGET, 2017, 8 (10) : 17279 - 17291
  • [7] The role and underlying mechanisms of tumour-derived exosomes in lung cancer metastasis
    He, Jinling
    Yang, Lingqi
    Zhou, Ning
    Zu, Lingling
    Xu, Song
    [J]. CURRENT OPINION IN ONCOLOGY, 2023, 35 (01) : 46 - 53
  • [8] Exosomes and Cell Communication: From Tumour-Derived Exosomes and Their Role in Tumour Progression to the Use of Exosomal Cargo for Cancer Treatment
    Nicolini, Andrea
    Ferrari, Paola
    Biava, Pier Mario
    [J]. CANCERS, 2021, 13 (04) : 1 - 24
  • [10] Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?
    T L Whiteside
    [J]. British Journal of Cancer, 2005, 92 : 209 - 211